Clinical Trials Logo
  1. Home
  2. Cardiometabolic Syndrome
  3. NCT06062836

The Platform for Interdisciplinary Cardiovascular-metabolic-neurovascular Diseases (PICMAN) — PICMAN  

Cardiometabolic Syndrome Clinical Trial

Official title:
The Platform for Interdisciplinary Cardiovascular-metabolic-neurovascular Diseases (PICMAN) Across National University Health System (NUHS)

Clinical Trial Summary

Background Changes in metabolism and mitochondrial function appear to precede cardiac dysfunction, with much evidence supporting metabolic dysregulation as one of the earliest precursors of cardiovascular disease. We hypothesise that quantifiable metabolic inflexibility may be representative of an individual in his/her silent, but high-risk progression towards insulin resistance, diabetes and cardiovascular disease. The platform for interdisciplinary cardiovascular-metabolic-neurovascular diseases (PICMAN) across National University Health System (NUHS) is a pilot, prospective, multi-ethnic cohort study in Singapore. Through extensive phenotyping in a preventive cardiology cohort, the central aim is to define the metabolic flexibility range in a cohort of individuals at elevated risk of atherosclerotic cardiovascular disease, to correlate metabolic flexibility to measures of cardiometabolic health, including diastolic dysfunction, coronary and cerebral atherosclerosis, body fat distribution and severity of non-alcoholic fatty liver disease.

Clinical Trial Description

Aims 1. Define norms for metabolic flexibility in a multi-ethnic Southeast Asian cohort of individuals without manifest ASCVD 2. Understand the association of metabolic inflexibility with cardiovascular measures of diastolic dysfunction and coronary and cerebral atherosclerosis 3. Understand the association of metabolic inflexibility with measures of body fat distribution 4. Understand the correlation between metabolic flexibility and insulin sensitivity along the spectrum of subclinical cardiovascular disease and severity of non-alcoholic fatty liver disease 5. Associations of the gut microbiome as well as metabolomic and molecular markers with cardio-cerebrovascular measures, metabolic flexibility and liver fibrosis The PICMAN study seeks to lay the foundations for further future larger scale and more experimentally ambitious studies based on the overarching hypothesis that metabolic flexibility is an early marker in subclinical cardiovascular disease, indicating a point of timely intervention where the disease process is still reversible. The importance of a deeply-phenotyped local cohort will allow us to study the progression of CVD in seemingly well adults, converging imaging, biochemical, metabolic markers, and 'omics analysis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06062836
Study type Observational [Patient Registry]
Source National University Hospital, Singapore
Contact Mayank Dalakoti
Phone +6566011036
Email mayank_dalakoti@nuhs.edu.sg
Status Recruiting
Phase
Start date April 1, 2022
Completion date April 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05880758 - Impact of Yo-Yo Sleep on Cardiometabolic Health N/A
Active, not recruiting NCT05192590 - Establishing Clinical Utility Evidence for Chronic Disease Management Testing N/A
Completed NCT06058845 - Efficacy of Tamarindus Indica Fruit Juice in Optimizing Cardiometabolic Health of Patients Living With HIV N/A
Completed NCT05473026 - Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors N/A
Enrolling by invitation NCT06284772 - FINRISK 2002 Re-examination
Completed NCT05071833 - Effects of Peppermint Oil in Cardiometabolic Outcomes N/A
Active, not recruiting NCT05309057 - Network Meta-analysis of Intermittent Fasting and Cardiometabolic Risk
Recruiting NCT05897073 - Time-Restricted Eating, Exercise and Cardiometabolic Health in Obesity N/A
Recruiting NCT06371937 - iPSC Biobank of Biomarkers Diversity in Cardiovascular Disease
Recruiting NCT06003686 - Spinal Cord Injury Model Systems (SCIMS) - Education Module N/A
Recruiting NCT05775016 - Effects of Adding L-BAIBA to Exercising Adult Overweight and Obese Men and Women N/A
Recruiting NCT05350111 - CArdioMetabolic Prevention in Adolescents N/A
Completed NCT06158191 - Long-term Benefits of Abdominal Fat Loss in Abdominally Obese Dyslipidemic Patients (SYNERGIE Study) N/A
Recruiting NCT04801745 - Vegan Diet, Amla Fruits and Uric Acid N/A
Not yet recruiting NCT06230861 - Effects of Quercetin on Cardiometabolic Outcomes N/A
Active, not recruiting NCT05627570 - A Study Comparing the Health Effects of Two Diets Following UK Dietary Guidance in People Living With Overweight or Obesity N/A
Active, not recruiting NCT04784624 - Virtual Lifestyle Program Evaluation During Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Enrolling by invitation NCT05079529 - Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic Syndrome Phase 2
Completed NCT04776629 - A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors Phase 2
Completed NCT06457711 - Blood Pressure and Cardiometabolic Risk (Diet-to-HTN) N/A